This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Pramod Sanghi: Innovator in Optical Coherence Tomography
In the realm of medical technology, Pramod Sanghi stands out as an inventive force. Based in Bloomfield, MI, Pramod has made significant contributions to the field of optical coherence tomography, particularly in the detection and treatment of cells.
Latest Patents
Pramod Sanghi is credited with a noteworthy patent titled "Optical coherence tomographic detection of cells and killing of the same." This innovative patent focuses on the use of optical coherence tomography (OCT) for the detection of cells and the subsequent destruction of those cells. The invention details systems, methods, and compositions that enable a detected cell to be killed or injured by contacting it with a special composition and applying energy to a particle associated with the cell.
Career Highlights
Pramod’s professional journey involves his current position at the University of Texas System, where he continues to pursue advancements in medical imaging technologies. His dedication and expertise have placed him at the forefront of research in the application of optical coherence tomography in clinical settings.
Collaborations
Throughout his career, Pramod has collaborated with notable researchers, including Marc D. Feldman and Thomas E. Milner. These collaborations highlight his commitment to pushing the boundaries of medical technology and improving patient outcomes through innovative research.
Conclusion
Pramod Sanghi exemplifies the innovative spirit necessary for advancements in the field of medical technology. His patent and ongoing work at the University of Texas System underscore the impact that dedicated inventors can have on healthcare. As technology continues to evolve, contributions like Pramod's will play a critical role in shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
